TCMBANKIN000393 |
Maingayinine |
|
|
|
|
TCMBANKIN000715 |
(E)-16α,17-dihydroxy-kauran-19-oic acid |
|
|
|
|
TCMBANKIN000815 |
3,9-diene juniper |
|
|
|
|
TCMBANKIN001292 |
Fissistigmine |
|
C20H23NO4 |
|
CN1CCC2=CC(=CC3=C2C1CC4=CC(=CC(=C4O3)OC)OC)OC |
TCMBANKIN001379 |
7-formyl-dehydrothalicsimidine |
|
C23H25NO6 |
411.4 g/mol |
CN1CCC2=C3C1=C(C4=CC(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)OC)C=O |
TCMBANKIN001574 |
(+ )-isocorydine a-N-oxide |
|
C20H23NO5 |
|
C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)OC)OC)[O-] |
TCMBANKIN001839 |
Enterocarpam-III |
|
|
|
|
TCMBANKIN002575 |
bullatanocin |
|
C37H66O8 |
638.9 g/mol |
CCCCCCCCCCC(C1CCC(O1)C(CCC(C2CCC(O2)CCCCCCCC(CC3=CC(OC3=O)C)O)O)O)O |
TCMBANKIN003358 |
Goniotamirine |
|
|
|
|
TCMBANKIN003875 |
l-kaur-16-en-19-oic acid |
l-kaur-16-en-19-oicacid |
C20H30O2 |
|
|
TCMBANKIN004083 |
dehydrodiscretamine |
Dehydrodiscretamine |
C19H18NO4+ |
324.3 g/mol |
COC1=CC2=C3C=C4C=CC(=C(C4=C[NH+]3CCC2=CC1=O)OC)O |
TCMBANKIN004216 |
Annosqualine |
|
C19H19NO5 |
341.4 g/mol |
COC1=C2CCN3C(C2=CC(=C1OC)O)CC4(C3=O)C=CC(=O)C=C4 |
TCMBANKIN004997 |
Demethylsonodione |
|
|
|
|
TCMBANKIN005033 |
Urabain |
|
C36H32N2O4 |
556.6 g/mol |
COC1=C(C2=C3C(=C1)CCNC3=C(C4=CC=CC=C42)C5=C6C7=C(C8=CC=CC=C85)C(=C(C=C7CCN6)OC)OC)OC |
TCMBANKIN005342 |
Fissistigamide B |
|
C19H18N2O5 |
354.4 g/mol |
COC1=CC2=CC3C4=C(CCN3C(=O)N)CC5=C(C4=C2C(=C1)O)OCO5 |
TCMBANKIN005457 |
squamostatin d |
|
C37H66O7 |
622.9 g/mol |
CCCCCCCCCCC(C1CCC(O1)C(CCC(C2CCC(O2)CCCCCCCCCC3=CC(OC3=O)C)O)O)O |
TCMBANKIN005761 |
Artabonatine B |
|
C18H17NO4 |
311.3 g/mol |
COC1=C2C(=C3C4=CC=CC=C4C(C5C3=C1CCN5)O)OCO2 |
TCMBANKIN005849 |
(-)-spinosine |
|
C19H21NO4 |
|
COC1=C(C=C2C3CC4=CC(=C(C=C4CN3CCC2=C1)O)O)OC |
TCMBANKIN006290 |
Dehydrolirinidine |
dehydrolirinidine |
C18H17NO2 |
279.3 g/mol |
CN1CCC2=CC(=C(C3=C2C1=CC4=CC=CC=C43)O)OC |
TCMBANKIN006381 |
bis-7,7'-dehydro-10,10'-dimethoxyanonaine |
|
C36H28N2O6 |
584.6 g/mol |
COC1=CC2=C(C=C1)C(=C3C4=C2C5=C(C=C4CCN3)OCO5)C6=C7C8=C(C9=C6C=CC(=C9)OC)C1=C(C=C8CCN7)OCO1 |
TCMBANKIN006621 |
Pseuduvarine B |
|
C19H16N2O4 |
336.3 g/mol |
CN1C2=CC3=CC=CC=C3C4=C2C(=C(C(=C4OC)OC)N)C(=O)C1=O |
TCMBANKIN007937 |
Fissisaine |
|
C20H20NO5+ |
354.4 g/mol |
COC1=C(C(=C2CC[N+]3=C(C2=C1)C=C4C=CC(=C(C4=C3)OC)O)O)OC |
TCMBANKIN009635 |
xylopine |
|
C18H17NO3 |
295.3 g/mol |
COC1=CC2=C(C=C1)C3=C4C(C2)NCCC4=CC5=C3OCO5 |
TCMBANKIN009667 |
10,11-dihydroxy-1,2-dimethoxynoraporphine |
|
C18H19NO4 |
|
COC1=C(C2=C3C(CC4=C2C(=C(C=C4)O)O)NCCC3=C1)OC |
TCMBANKIN010276 |
(-)-asimilobine |
|
C17H17NO2 |
267.32 g/mol |
COC1=C(C=C2CCNC3C2=C1C4=CC=CC=C4C3)O |
TCMBANKIN010558 |
thalicsimidine |
|
C22H27NO5 |
385.45 |
CN1CCC2=C3C1CC4=CC(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)OC |
TCMBANKIN010724 |
Annobraine |
|
C19H11NO4 |
317.3 g/mol |
C1CN2C3=C(C4=CC=CC=C4C5=C3C1=CC6=C5OCO6)C(=O)C2=O |
TCMBANKIN011416 |
romucosine h |
Romucosine H |
C21H23NO6 |
385.4 g/mol |
COC1=C(C2=C(CC3C4=C2C(=C(C=C4CCN3C(=O)OC)OC)OC)C=C1)O |
TCMBANKIN012741 |
Norfissilandione |
|
C18H13NO5 |
323.3 g/mol |
COC1=CC(=O)C2=C3C4=C(C=C2C1=O)NCC=C4CC5=C3OCO5 |
TCMBANKIN012896 |
16α-hydro-19-al-ent-kauran-17-oicacid |
|
C20H30O3 |
|
CC1(CCCC2(C1CCC34C2CCC(C3)C(C4)C(=O)O)C)C=O |
TCMBANKIN014211 |
N-methyl-2,3,6-trimethoxymorphinandien-7-one |
|
|
|
|
TCMBANKIN014736 |
equisetrin |
|
C27H30O16 |
|
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)COC5C(C(C(C(O5)CO)O)O)O)O)O)O)O)O)O |
TCMBANKIN014978 |
4α-hydroxy-19-nor-ent-kauran-17-oicacid |
|
C19H30O3 |
|
|
TCMBANKIN014998 |
(-)-roemerine |
|
C18H17NO2 |
279.3 g/mol |
CN1CCC2=CC3=C(C4=C2C1CC5=CC=CC=C54)OCO3 |
TCMBANKIN015974 |
Asimilobine |
6871-21-2; 125678-63-9; (+)-Asimilobine; 4H-Dibenzo(de,g)quinolin-2-ol, 5,6,6a,7-tetrahydro-1-methoxy-, (R)-; CHEMBL389271; asimilobine |
C17H17NO2 |
267.32 |
COC1=C(C=C2CCNC3C2=C1C4=CC=CC=C4C3)O |
TCMBANKIN016592 |
Duguevanine |
|
C20H21NO5 |
355.4 g/mol |
COC1=CC2=C(C(=C1)OC)C3=C4C(=C(C5=C3C(C2)NCC5)OC)OCO4 |
TCMBANKIN017436 |
aristololactam GII |
|
C16H11NO4 |
281.26 g/mol |
COC1=C(C2=C3C=C(C=CC3=CC4=C2C(=C1)C(=O)N4)O)O |
TCMBANKIN017921 |
stigmalactam |
|
C18H15NO5 |
325.3 g/mol |
COC1=C(C(=C2C3=C(C=C4C=CC(=CC4=C31)O)NC2=O)OC)OC |
TCMBANKIN018163 |
Thalicpureine |
thalicpureine |
C22H27NO5 |
385.5 g/mol |
CNCCC1=C2C=CC3=CC(=C(C=C3C2=C(C(=C1OC)OC)OC)OC)OC |
TCMBANKIN019088 |
thalbaicalidine |
Thalbaicalidine |
C21H25NO5 |
371.43 |
CN1CCC2=C3C1CC4=CC(=C(C=C4C3=C(C(=C2O)OC)OC)OC)OC |
TCMBANKIN020398 |
squasapogenol |
|
C30H48O2 |
440.7 g/mol |
CC1(CC(C2(CCC3(C(=C2C1)C=CC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C)C)O)C |
TCMBANKIN020430 |
(-)-N-methylguattescidine |
|
|
|
C19H17NO4 |
TCMBANKIN020440 |
Fissistigamide A |
|
C19H18N2O4 |
338.4 g/mol |
COC1=CC2=CC3C4=C(CCN3C(=O)N)CC5=C(C4=C2C=C1)OCO5 |
TCMBANKIN020637 |
1,9-dihydroxy-2,11-dimethoxy-4,5-dihydro-7-oxoaporphine |
|
|
|
|
TCMBANKIN020776 |
7-hydroxy-dehydroglaucine |
|
C21H23NO5 |
369.4 g/mol |
CN1CCC2=CC(=C(C3=C2C1=C(C4=CC(=C(C=C43)OC)OC)O)OC)OC |
TCMBANKIN020812 |
Cerasonine |
|
C20H19NO5 |
353.4 g/mol |
COC1=C(C=C2C(=C1)CCN3C2=CC4=CC(=C(C=C4C3=O)OC)OC)O |
TCMBANKIN020978 |
17-hydroxy-16β-ent-kauran-19-oicacid |
|
C20H32O3 |
|
CC12CCCC(C1CCC34C2CCC(C3)C(C4)CO)(C)C(=O)O |
TCMBANKIN021076 |
Oxocalycinine |
|
C18H11NO5 |
321.3 g/mol |
COC1=CC2=C(C(=C1)O)C3=C4C(=CC5=C3OCO5)C=CN=C4C2=O |
TCMBANKIN021145 |
Artabotrysine |
|
|
|
|
TCMBANKIN021457 |
Corytenchine |
|
C20H23NO4 |
341.4 g/mol |
COC1=C(C=C2C3CC4=CC(=C(C=C4CN3CCC2=C1)OC)O)OC |
TCMBANKIN021720 |
Discretine N-oxide |
|
C20H23NO5 |
357.4 g/mol |
COC1=C(C=C2C[N+]3(CCC4=CC(=C(C=C4C3CC2=C1)OC)O)[O-])OC |
TCMBANKIN021982 |
aristolactam F II |
aristolactam fii |
C17H13NO4 |
295.29 g/mol |
COC1=C(C(=C2C3=C1C4=CC=CC=C4C=C3NC2=O)OC)O |
TCMBANKIN022492 |
Sampangine |
|
C15H8N2O |
232.24 g/mol |
C1=CC=C2C(=C1)C3=NC=CC4=C3C(=NC=C4)C2=O |
TCMBANKIN023436 |
Desmorostratine |
|
C20H21NO5 |
355.4 g/mol |
COC1=C(C2=C(C=C1)C3=C4C(=C(C5=C3C(C2)NCC5)OC)OCO4)OC |
TCMBANKIN023756 |
Prolifine |
|
|
|
|
TCMBANKIN024375 |
(?)-17-hydroxy-16β-kauran-19-oicacid |
|
C20H32O3 |
|
|
TCMBANKIN024669 |
annonin vi |
|
C37H66O7 |
622.9 g/mol |
CCCCCCCCCCC(C1CCC(O1)C2CCC(O2)C(CCCCCCCCCCC(CC3=CC(OC3=O)C)O)O)O |
TCMBANKIN025236 |
aristololactam GI |
|
C26H21NO6 |
443.4 g/mol |
CC1C(OC2=C(O1)C=C3C4=C2C5=CC=CC=C5C=C4NC3=O)C6=CC(=C(C(=C6)OC)O)OC |
TCMBANKIN026170 |
squamotacin |
|
C37H66O7 |
622.9 g/mol |
CCCCCCCCCCCCC(C1CCC(O1)C2CCC(O2)C(CCCCCCCCC(CC3=CC(OC3=O)C)O)O)O |
TCMBANKIN026824 |
CREBANINE |
NSC335648; NCI60_002939; Crebanine |
C20H21NO4 |
339.39 |
CN1CCC2=CC3=C(C4=C2C1CC5=C4C=CC(=C5OC)OC)OCO3 |
TCMBANKIN027461 |
griffithinam |
|
C17H13NO4 |
295.29 g/mol |
COC1=CC=CC2=C3C4=C(C=C21)NC(=O)C4=CC(=C3O)OC |
TCMBANKIN027619 |
(+ )-predicentrine |
(+)-predicentrine |
C20H23NO4 |
341.4 g/mol |
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)OC)O |
TCMBANKIN027643 |
N-formyl-purpureine |
|
C22H25NO6 |
399.4 g/mol |
COC1=C(C=C2C(=C1)CC3C4=C(CCN3C=O)C(=C(C(=C24)OC)OC)OC)OC |
TCMBANKIN027713 |
bis-7,7'-dehydroanonaine |
|
|
|
|
TCMBANKIN028295 |
retrorsine |
.beta.-Longilobine; BCJMNZRQJAVDLD-XRVQXMHSSA-N; RETRORSINE |
C18H25NO6 |
351.4 g/mol |
CC=C1CC(C(C(=O)OCC2=CCN3C2C(CC3)OC1=O)(CO)O)C |
TCMBANKIN030410 |
4,5-dioxodehydro asimilobine |
4,5-dioxodehydroasimilobine |
C17H11NO4 |
293.27 g/mol |
COC1=C(C=C2C3=C1C4=CC=CC=C4C=C3NC(=O)C2=O)O |
TCMBANKIN030645 |
Fissilandione |
|
C19H15NO5 |
337.3 g/mol |
CN1CC=C2CC3=C(C4=C5C(=CC1=C24)C(=O)C(=CC5=O)OC)OCO3 |
TCMBANKIN031135 |
Calycinine |
|
C18H17NO4 |
311.3 g/mol |
COC1=CC2=C(C(=C1)O)C3=C4C(C2)NCCC4=CC5=C3OCO5 |
TCMBANKIN031281 |
bis-7,7'-dehydro-8,8'-dimethoxyanonaine |
|
C36H28N2O6 |
584.6 g/mol |
COC1=CC=CC2=C1C(=C3C4=C2C5=C(C=C4CCN3)OCO5)C6=C7C8=C(C9=C6C(=CC=C9)OC)C1=C(C=C8CCN7)OCO1 |
TCMBANKIN031713 |
(-)-attavenustine |
|
C18H19NO4 |
|
COC1=C(C=C2CCN3CC4=CC(=C(C=C4CC3C2=C1)O)O)O |
TCMBANKIN031869 |
10-hydroxyliriodenine |
|
C17H9NO4 |
291.26 g/mol |
C1OC2=C(O1)C3=C4C(=C2)C=CN=C4C(=O)C5=C3C=C(C=C5)O |
TCMBANKIN031958 |
Aporphin |
|
C19H22ClNO3 |
|
C[NH+]1CCC2=CC(=C(C3=C2C1CC4=C3C(=CC=C4)OC)O)OC.[Cl-] |
TCMBANKIN032024 |
7-dehydroanonaine-7-dehydro-8-methoxyanonaine |
|
|
|
|
TCMBANKIN032944 |
N-methyllaurotetanine |
n-methyllaurotetanine |
C20H23NO4 |
341.4 |
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)O)OC)OC |
TCMBANKIN033390 |
Oldhamactam |
|
C18H15NO5 |
325.3 g/mol |
COC1=C(C(=C2C3=C(C=C4C(=C31)C=CC=C4O)NC2=O)OC)OC |
TCMBANKIN033492 |
Pseuduvarine A |
|
C18H14N2O4 |
322.3 g/mol |
COC1=C(C(=C2C3=C1C4=CC=CC=C4C=C3NC(=O)C2=O)N)OC |
TCMBANKIN033496 |
3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one |
3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone |
C21H20O11 |
448.4 g/mol |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O |
TCMBANKIN034152 |
momorcharaside a |
momorcharaside a |
C42H72O15 |
817 g/mol |
CC(C1CCC2(C1(CCC3(C2CC=C4C3CCC(C4(C)C)OC5C(C(C(C(O5)COC6C(C(C(C(O6)CO)O)O)O)O)O)O)C)C)C)C(C(C(C(C)(C)O)O)O)O |
TCMBANKIN034549 |
Thaipetaline |
|
C20H23NO5 |
357.4 g/mol |
COC1=C(C(=C2CCN3CC4=C(CC3C2=C1)C=CC(=C4OC)O)O)OC |
TCMBANKIN034613 |
Norpurpureine |
|
C21H25NO5 |
371.4 g/mol |
COC1=C(C=C2C(=C1)CC3C4=C(CCN3)C(=C(C(=C24)OC)OC)OC)OC |
TCMBANKIN035062 |
squamosamide |
|
C26H27NO7 |
465.5 g/mol |
COC1=CC(=CC(=C1O)OC)C(=CC2=CC(=C(C=C2)O)OC)C(=O)NCCC3=CC=C(C=C3)O |
TCMBANKIN035235 |
Cerasodine |
|
C19H17NO5 |
339.3 g/mol |
COC1=C(C=C2C(=C1)CCN3C2=CC4=CC(=C(C=C4C3=O)O)OC)O |
TCMBANKIN035297 |
squamocin |
|
C37H66O7 |
622.9 g/mol |
CCCCCCC(CCCC(C1CCC(O1)C2CCC(O2)C(CCCCCCCCCCCCC3=CC(OC3=O)C)O)O)O |
TCMBANKIN035530 |
Oxoaporphin |
|
C20H21NO4 |
|
CN1CCC2=CC(=C(C3=C2C1C(=O)C4=C3C=C(C=C4)OC)OC)OC |
TCMBANKIN035807 |
Oxodiscoguattine |
|
C19H13NO5 |
335.3 g/mol |
COC1=CC2=C(C(=C1)OC)C3=C4C(=CC5=C3OCO5)C=CN=C4C2=O |
TCMBANKIN036060 |
Isolaureline |
|
C19H19NO3 |
309.4 g/mol |
CN1CCC2=CC3=C(C4=C2C1CC5=C4C=CC(=C5)OC)OCO3 |
TCMBANKIN036111 |
Lastourvilline |
|
C19H21NO4 |
327.4 g/mol |
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)O)O |
TCMBANKIN036142 |
Isocoreximine |
|
C19H21NO4 |
327.4 g/mol |
COC1=C(C=C2CC3C4=CC(=C(C=C4CCN3CC2=C1)O)OC)O |
TCMBANKIN036277 |
2,10-dimethoxy-3,11-dihydroxy-5,6-dihydroprotoberberine |
|
|
|
|
TCMBANKIN036399 |
aristololactam B III |
|
C18H15NO4 |
309.3 g/mol |
COC1=CC2=C3C4=C(C=C2C=C1)NC(=O)C4=CC(=C3OC)OC |
TCMBANKIN036772 |
7-hydroxy-dehydrothalicsimidine |
|
C22H25NO6 |
399.4 g/mol |
CN1CCC2=C3C1=C(C4=CC(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)OC)O |
TCMBANKIN036782 |
squamostatin b |
|
C37H66O8 |
638.9 g/mol |
CCCCCCC(CCCC(C1CCC(O1)C(CCC(C2CCC(O2)CCCCCCCCCC3=CC(OC3=O)C)O)O)O)O |
TCMBANKIN037738 |
cheliensisine |
|
C20H20N2O5 |
|
|
TCMBANKIN038035 |
Bullatacin |
|
|
622.9 g/mol |
|
TCMBANKIN038570 |
romucosine g |
Romucosine G |
C23H27NO7 |
|
COC1=C(C=C2C(=C1)CC3C4=C2C(=C(C(=C4CCN3C(=O)OC)OC)OC)OC)OC |
TCMBANKIN038610 |
Artabonatine E |
|
|
337.3 g/mol |
|
TCMBANKIN038621 |
artabonatine c |
|
C19H15NO4 |
321.3 g/mol |
COC1=C2C3=CC=CC=C3C(=O)C4=NC(=C(C(=C24)C=C1)OC)OC |
TCMBANKIN038711 |
Columbamine |
BDBM50226664; Dibenzo[a,g]quinolizinium, 5,6-dihydro-2-hydroxy-3,9,10-trimethoxy-; SCHEMBL422073; HY-N0926; AKOS030526792; CS-4254; STOCK1N-48595; 5,6-dihydro-2-hydroxy-3,9,10-trimethoxydibenzo[a,g]quinolizinium; FT-0723334; 3621-36-1; 7T4808FEJW; 2-hydroxy-3,9,10-trimethoxy-5,6-dihydroisoquino[3,2-a]isoquinolinium; AC1Q7BDJ; CHEBI:15920; KS-00000TTK; DTXSID80189766; 3,9,10-trimethoxy-5,6-dihydroisoquinolino[3,2-a]isoquinolin-7-ium-2-ol; CTK4H6087; AC1L2HU1; Dibenzo(a,g)quinolizinium, 5,6-dihydro-2-hydroxy-3,9,10-trimethoxy-; C01795; 5,6-Dihydro-2-hydroxy-3,9,10-trimethoxydibenzo[a,g]quinolizinium iodide; columbamine ; MCULE-1960820824; 3,9,10-trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-2-ol; UNII-7T4808FEJW; Dehydroisocorypalmine; 7,8,13,13a-tetradehydro-2-hydroxy-3,9,10-trimethoxyberbinium; MolPort-002-523-367; YYFOFDHQVIODOQ-UHFFFAOYSA-O; Dibenzo[a,g]quinolizinium,5,6-dihydro-2-hydroxy-3,9,10-trimethoxy-; LS-182873; ZINC338120; AK547771; Columbamine; 9161AF; CHEMBL400345 |
C20H20NO3 |
323 |
c1(OC([H])([H])[H])c([H])c(C([H])([H])C([H])([H])N(C([H])=C(C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C2[H])C2=C3[H])=C34)c4c([H])c1[H] |
TCMBANKIN040256 |
norcepharadione B |
CHEMBL227414; AKOS028108617; Norcepharadione B; 15,16-DIMETHOXY-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(17),2(7),3,5,8,13,15-HEPTAENE-11,12-DIONE; ZINC6017923; AC1Q6OMU; W1102; 1,2-dimethoxy-4h-dibenzo[de,g]quinoline-4,5(6h)-dione; 15,16-DIMETHOXY-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(16),2,4,6,8,13(17),14-HEPTAENE-11,12-DIONE; 57576-41-7; 4CN-2031; CTK5A7091; AC1L4O6W; 4H-Dibenzo[de,g]quinoline-4,5(6H)-dione, 1,2-dimethoxy-; norcepharadione; BG01598744; MolPort-035-705-677; DTXSID80206205 |
C18H13NO4 |
307.3 |
c1(OC([H])([H])[H])c([H])c2c(c(N([H])C(=O)C2=O)c([H])c(c([H])c([H])c([H])c3[H])c34)c4c1OC([H])([H])[H] |
TCMBANKIN041088 |
Annomosin A |
|
|
620.9 g/mol |
|
TCMBANKIN041291 |
16α,17-dihydroxy-ent-kauran-19-al |
|
C20H30O3 |
|
CC1(C(CCC2(C1CC(=O)C34C2CCC(C3)C(=C4)CO)C)O)C |
TCMBANKIN042193 |
17-Hydroxy-16β-ent-kauran-19-al |
|
|
|
|
TCMBANKIN042245 |
O-Methylmoschatoline |
|
|
321.3 g/mol |
|
TCMBANKIN043186 |
Kikemanine |
|
C20H23NO4 |
341.401 |
C([H])([H])([H])Oc1c([H])c(C([H])([H])C([H])([H])N(C([H])([H])c(c(OC([H])([H])[H])c(O[H])c([H])c2[H])c2C3([H])[H])[C@@]34[H])c4c([H])c1OC([H])([H])[H] |
TCMBANKIN043609 |
uncinine |
|
C12H15NO3 |
221.25 g/mol |
CC(=C1C=C(C(=O)O1)CN2CCCC2=O)C |
TCMBANKIN043667 |
Annosquamosin D |
|
|
350.5 g/mol |
|
TCMBANKIN044043 |
Goniothalactam |
|
|
295.29 g/mol |
|
TCMBANKIN044723 |
griffithdione |
|
C19H15NO4 |
321.3 g/mol |
CC1=C2C3=C(C4=CC=CC=C14)C(=C(C=C3C(=O)C(=O)N2)OC)OC |
TCMBANKIN044811 |
Oxopurpureine |
|
|
381.4 g/mol |
|
TCMBANKIN045236 |
fetidine |
Fetidine; SCHEMBL2989372; SureCN2989372; C09441; CHEBI:5049; (6aS)-9-[6-[[(1S)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2,3-dimethoxy-phenoxy]-2,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1-ol; DTXSID10331776; 7072-86-8; AC1L9CGQ |
C40H46N2O8 |
682.8 g/mol |
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC5=C(C=CC(=C5OC)OC)CC6C7=CC(=C(C=C7CCN6C)OC)OC)O)OC |
TCMBANKIN045423 |
lanuginosine |
|
C18H11NO4 |
305.3 g/mol |
COC1=CC2=C(C=C1)C3=C4C(=CC5=C3OCO5)C=CN=C4C2=O |
TCMBANKIN045729 |
artabonatine f |
|
C36H28N2O6 |
584.6 g/mol |
COC1=C2C(=C3C4=CC=CC=C4C(=C5C3=C1CCN5)C6=C7C8=C(CCN7)C(=C9C(=C8C1=CC=CC=C16)OCO9)OC)OCO2 |
TCMBANKIN045899 |
16β,17-dihydroxy-ent-kauran-19-al |
|
C20H32O3 |
|
CC1(CCCC2(C1CCC34C2CCC(C3)C(C4)(CO)O)C)C=O |
TCMBANKIN046105 |
annosquamosin f |
|
C21H34O5 |
366.5 g/mol |
CC(=O)OCC1(CC23CCC4C(C2CCC1C3)(CCCC4(C)OO)C)O |
TCMBANKIN046955 |
romucosine f |
Romucosine F |
C22H24 ClNO6 |
|
|
TCMBANKIN047393 |
annosquamosin c |
|
C19H32O2 |
292.5 g/mol |
CC12CCCC(C1CCC34C2CCC(C3)C(C4)CO)(C)O |
TCMBANKIN048004 |
Lirinidine |
AC1LGHD7; (?)-Lirinidine; CHEMBL2316500; (-)-Lirinidine; SCHEMBL4159150 |
|
281.3 g/mol |
|
TCMBANKIN049682 |
Squamocenin |
|
|
|
|
TCMBANKIN050378 |
annosquamosin g |
|
C19H32O4 |
324.5 g/mol |
CC12CCCC(C1CCC34C2CCC(C3)C(C4)(CO)O)(C)OO |
TCMBANKIN052591 |
10-amino-3,6-dihydroxy-2,4-dimethoxyphenanthrene-1-carboxylic acid lactam |
10-amino-2,4-dimethoxyphenanthrene-1-carboxylicacid lactam; 10-amino-2,4-dimethoxyphenanthrene-1carboxylie acid lactam |
C17H13NO3 |
|
COC1=CC(=C2C3=C1C4=CC=CC=C4C=C3NC2=O)OC |
TCMBANKIN053990 |
Nigakilactone E |
19-nor-ent-kaurane-4α,16β,17-triol |
C24H34O8 |
|
[C@@]1([H])(OC([H])([H])[H])[C@](O[H])(C([H])([H])[H])[C@@]2([H])[C@](C([H])([H])[H])([C@]([H])(OC(=O)C2([H])[H])C([H])([H])[C@]([H])([C@]([H])(C([H])([H])[H])C([H])=C(OC([H])([H])[H])C3=O)[C@]34C([H]
)([H])[H])[C@]4([H])[C@]1([H])OC(=O)C([H])([H])[H] |
TCMBANKIN057963 |
succinic acid |
NCGC00159372-02; AIDS017693; Bernsteinsaure; succ; nchembio856-comp9; SIN; Butanedioic acid diammonium salt; InChI=1/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8; Bernsteinsaeure; ST5213944; nchembio.2007.47-comp2; 4-02-00-01908 (Beilstein Handbook Reference); 623158-99-6; LMFA01170043; BRN 1754069; butanedioic acid; Succinic acid (8CI); acide butanedioique; Dihydrofumaric acid; Katasuccin; 110-15-6; WLN: QV2VQ; FMR; AI3-06297; EINECS 203-740-4; Kyselina jantarova [Czech]; Amber acid; 398055_SIAL; 1,4-Butanedioic acid; S3674_SIAL; succinicacid; Ethylene dicarboxylic acid; 1,4-BUTANEDIOIC ACID (SUCCINIC ACID); S7501_SIAL; NSC25949; Bernsteinsaure [German]; acide succinique; NSC 106449; HOOC-CH2-CH2-COOH; Butandisaeure; 1,2-Ethanedicarboxylic acid; Acidum succinicum; Asuccin; C00042; Wormwood acid; ethylenesuccinic acid; Wormwood; 14078_FLUKA; Butanedionic acid; NSC106449; W502707_ALDRICH; W502715_ALDRICH; NCGC00159372-03; AIDS-017693; spirit of amber; A 12084; CHEBI:15741; Butanedioic acid (9CI); S9512_SIGMA; 14079_FLUKA; HSDB 791; Amber acid; amber acid |
C4H6O4 |
118.09 g/mol |
C(CC(=O)O)C(=O)O |
TCMBANKIN058217 |
kaempferol-7-O-β-D-glucopyranoside |
3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; kaempferol 7-O-β-D-glucopyranoside; kaempferol-7-o-glucoside; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one |
C21H20O11 |
448.4 g/mol |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O |
TCMBANKIN058329 |
glucotropaeolin |
tropaeolin |
C14H19NO9S2 |
409.4 g/mol |
C1=CC=C(C=C1)CC(=NOS(=O)(=O)O)SC2C(C(C(C(O2)CO)O)O)O |
TCMBANKIN058641 |
(-)-anonaine |
C09339; 3,5-DIOXA-11-AZAPENTACYCLO[10.7.1.0(2),?.0?,(2)?.0(1)?,(1)?]ICOSA-1(20),2(6),7,14,16,18-HEXAENE; 1862-41-5; SCHEMBL15800852; 3,5-dioxa-11-azapentacyclo[10.7.1.0;{2,6}.0;{8,20}.0;{14,19}]icosa-1(20),2(6),7,14(19),15,17-hexaene; 1,2-Methylenedioxynoraporphine; Anonaine; J3.604.525F; Anonain; ACon1_001472; NCGC00180471-01; AC1MR46Q; (-)-Annonaine; 5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinoline, 6,7,7a,7-tetrahydro-, (R)-; (+)-Anonaine;anonaine |
C17H15NO2 |
265.31 g/mol |
C1CNC2CC3=CC=CC=C3C4=C2C1=CC5=C4OCO5 |
TCMBANKIN058658 |
Micheline B |
CCRIS 1549; Oxoushinsunin; C09567; 475-75-2; 8H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-one; Spermatheridin; NCI60_001798; MEGxp0_001521; BRN 0273167; Spermatheridine; Noraporphin-7-one, 4,5,6,6a-tetradehydro-1,2-(methylenedioxy)-; NSC93681; NSC215254; Liriodenine; Oxoushinsunine; NSC 215254; 8H-Benzo[g]-1,3-benzodioxolo[6,5,4-de]quinolin-8-one; Ushinsunine, oxo-; NORAPORPHIN-7-ONE, 4,5,6,6a-TETRAHYDRO-1,2-(METHYLENEDIOXY)-; 8H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-one (9CI); AIDS-008761; AIDS008761; NCI60_042088; NSC 93681; 4-27-00-06585 (Beilstein Handbook Reference) |
C17H9NO3 |
275.26 g/mol |
C1OC2=C(O1)C3=C4C(=C2)C=CN=C4C(=O)C5=CC=CC=C53 |
TCMBANKIN059038 |
annosquamosin e |
16β-hydroxy-17-acetoxy-ent-kauran-19-oicacid |
C22H34O5 |
378.5 g/mol |
CC(=O)OCC1(CC23CCC4C(C2CCC1C3)(CCCC4(C)OC=O)C)O |
TCMBANKIN060128 |
(-)-17-hydroxy-16beta-kauran-19-oic acid |
|
|
|
CC12CCCC(C1CCC34C2CCC(C3)C(C4)(CO)O)(C)C(=O)O |
TCMBANKIN060129 |
annosquamosin b |
|
C19H32O3 |
308.5 g/mol |
CC12CCCC(C1CCC34C2CCC(C3)C(C4)(CO)O)(C)O |
TCMBANKIN060130 |
16α-hydro-ent-kauran-17,19-dioicacid |
|
C20H30O4 |
|
CC12CCCC(C1CCC34C2CCC(C3)C(C4)C(=O)O)(C)C(=O)O |
TCMBANKIN060998 |
22-epimolvizarin; parviflorin; asimicin |
|
C35H62O7 |
594.9 g/mol |
CCCCCCCCCCC(C1CCC(O1)C2CCC(O2)C(CCCCCCCCC(CC3=CC(OC3=O)C)O)O)O |
TCMBANKIN061023 |
squamone |
|
C35H62O7 |
594.9 g/mol |
CCCCCCCCCCCCC(C1CCC(O1)C(CCCCCC(=O)CCCCC2CC(C(=O)O2)CC(=O)C)O)O |
TCMBANKIN061122 |
tricosane |
|
C23H48 |
324.63 g/mol |
CCCCCCCCCCCCCCCCCCCCCCC |
TCMBANKIN061324 |
d-reticuline |
(S)-(+)-reticuline; (1S)-1-[(3-hydroxy-4-methoxy-phenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; CHEBI:16718; 485-19-8; (1S)-1-(3-hydroxy-4-methoxy-benzyl)-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; (+)-Reticuline; (1S)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; (1S)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; C02105;CHEBI:17428; AC1L99KR; (R)-(-)-reticuline; (1R)-1,2,3,4-Tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol; AK552295; (1R)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; C05178; FT-0699770; MFCD28556897; ZINC901258; DTXSID80331501; L-Reticuline; CHEMBL401501; AKOS030242061; (1R)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; (R)-Reticuline; (-)-reticuline; SCHEMBL9587509; NCGC00247617-01; 3968-19-2; (R)-Reticuline (>80% ee); CTK1C2641; (S)-Reticuline;reticuline;reticulin |
C19H23NO4 |
329.4 g/mol |
CN1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)O)O)OC |
TCMBANKIN061329 |
corytuberine |
SCHEMBL11250377; AKOS016023668; CORYTUBERINE, PENTAHYDRATE; NSC406033; NSC-406033; 1,11-Dihydroxy-2,10-dimethoxyaporphine; AC1L874Y; AC1Q7AYD; (+)-corytuberine |
C19H21NO4 |
327.4 g/mol |
CN1CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)O)OC |
TCMBANKIN061330 |
Luteanin |
Artabotrin; Spectrum5_000378; BSPBio_000474; AIDS-138466; KBio2_004255; SPBio_000352; Prestwick1_000597; 545368_ALDRICH; KBio2_006823; Spectrum_001207; 6aalpha-Aporphin-11-ol, 1,2,10-trimethoxy- (8CI); KBio1_001557; BSPBio_002533; 1,2,10-Trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-ol; 4H-Dibenzo(de,g)quinolin-11-ol, 5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S)- (9CI); KBio3_001753; Prestwick3_000597; KBio2_001687; d-Isocorydine; NSC645316; SBB005942; Prestwick2_000597; 5-21-06-00132 (Beilstein Handbook Reference); NCGC00016453-02; S-(+)-Isocorydine; Luteanine (VAN); KBioSS_001687; 6a-alpha-APORPHIN-11-OL, 1,2,10-TRIMETHOXY-; Isocorydine; Spectrum2_000566; ()-Isocorydine; SpecPlus_000517; SDCCGMLS-0066694.P001; BPBio1_000522; AIDS138466; CAS-475-67-2; Luteanine; BRN 0094792; Prestwick_281; Isocorydine (+); NSC 645316; KBioGR_001998; Prestwick0_000597; C09549; Artabotrine; TNP00260; L-(+)-Isocorydine; NSC 32979; Lindcarpine, N,O-dimethyl-; SPECTRUM1500860; DivK1c_006613; Aporphin-11-ol, 1,2,10-trimethoxy-; 4H-Dibenzo(de,g)quinolin-11-ol, 5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S)-; SPBio_002693; Spectrum4_001699; NCGC00016453-01; Spectrum3_000717; 475-67-2; Uzokoridin; NCGC00142508-01;isocorydine;AC1OCG6Z; (-)-tramadol(1+); FT-0675348; ZB000501; [(1S,2S)-2-hydroxy-2-(3-methoxyphenyl)cyclohexyl]methyl-dimethylazanium; (S,S)-tramadol(1+); {[(1S,2S)-2-HYDROXY-2-(3-METHOXYPHENYL)CYCLOHEXYL]METHYL}DIMETHYLAZANIUM; [(1S,2S)-2-hydroxy-2-(3-methoxyphenyl)cyclohexyl]-N,N-dimethylmethanaminium; CHEBI:75738 |
C20H23NO4 |
341.4 g/mol |
CN1CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)OC)OC |
TCMBANKIN061333 |
Izoteolin |
Isoteolin; ST057702; 4H-Dibenzo(de,g)quinolinediol, 5,6,6a,7-tetrahydro-2,9(or 2,10)-dimethoxy-6-methyl-, (S)-; 95508-61-5; TNP00331; C09541; NCGC00142559-01; Isoboldine; Isoteoline; 6aalpha-Aporphine-1,9-diol, 2,10-dimethoxy-; NCGC00017381-01; isoboldine |
C19H21NO4 |
327.4 g/mol |
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)O)O)OC |
TCMBANKIN061334 |
glaucine |
AC1LL50T; (R)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo(de,g)quinoline; 38325-02-9; ZINC792622; EINECS 253-881-0; 4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-, (R)-; FT-0698454; (?)-Glaucine; RUZIUYOSRDWYQF-OAHLLOKOSA-N; l-Glaucine; DTXSID70191691; (R)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline; Glauvent ;(-)-glaucine; Bromcholitin; (+)-Glaucine; AIDS011385; GLAUCINE,(D); Glaucine; 6a.alpha.-Aporphine, 1,2,9,10-tetramethoxy-; NSC34396; S-(+)-Glaucine; C09446; Glaucine fumarate; BB_NC-0833; d-Glaucine; 4H-Dibenzo[de,g]quinoline, 5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-, (S)-; Boldine dimethyl ether; 475-81-0; AIDS-011385 |
C21H25NO4 |
355.43 |
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)OC)OC |
TCMBANKIN061340 |
n-methylasimilobine |
1-Methoxy-6a-beta-Aporphin-2-ol; 16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0;{2,7}.0;{13,17}]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol; (-)-N-Methylasimilobine; N-Methyl-Asimilobine; 16-METHOXY-10-METHYL-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(17),2,4,6,13,15-HEXAEN-15-OL; AKOS032949134; Floribundine; 2-hydroxy-1-methoxyaporphine; floribundine |
C18H19NO2 |
281.35 |
CN1CCC2=CC(=C(C3=C2C1CC4=CC=CC=C43)OC)O |
TCMBANKIN061553 |
aristololactam A IIIa;aristolactam aiiia |
aristololactam a iiia |
C16H11NO4 |
281.26 g/mol |
COC1=C(C=C2C3=C(C=C4C=CC(=CC4=C31)O)NC2=O)O |
TCMBANKIN061554 |
aristolactam aii |
NSC615450; Dibenz[cd,f]indol-4(5H)-one,2-hydroxy-1-methoxy-; 53948-07-5; Aristolactam-aii; Dibenz(cd,f)indol-4(5H)-one, 2-hydroxy-1-methoxy-; DTXSID50202234; aristololactam A II; 14-HYDROXY-15-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2(7),3,5,8,12,14-HEPTAEN-11-ONE; ZINC1612828; Dibenz[cd,f]indol-4(5H)-one, 2-hydroxy-1-methoxy-; CHEMBL390368; MolPort-039-141-798; AC1L3XKK; CCRIS 2996; 9099AF; AKOS028108588; Aristolactam AII; NSC-615450; aristololactam A II; aristolactam a |
C16H11NO3 |
265.26 g/mol |
COC1=C(C=C2C3=C1C4=CC=CC=C4C=C3NC2=O)O |
TCMBANKIN061556 |
(-)-pessoine |
pessoine |
C18H19NO4 |
313.3 g/mol |
COC1=C(C=C2C3CC4=CC(=C(C=C4CN3CCC2=C1)O)O)O |
TCMBANKIN061574 |
feruloyltyramine |
n- cis-feruloyltyramine; NP-001984; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; NCGC00169550-01; N-Trans-Feruloyl Tyramine; Moupinamide, >=95% (LC/MS-ELSD); 66648-43-9; Alfrutamide; trans-N-Feruloyltyramine; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; N-Feruloyltyramine; ZINC901461; MEGxp0_000693; Feruloyltyramine; Moupinamide; BRD-K98045316-001-01-0; MolPort-001-740-847; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; MCULE-4768764740; n-trans-feruloyl-tyramine; W1092; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; ACon1_001233; N-trans-Feruloyltyramine; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; CHEMBL206555; 65646-26-6; n- trans-feruloyltyramine; N-Transferuloyl Tyramine; MFCD17214811; AKOS025287596; CHEBI:17818; C02717; AC1NQX6M; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; CHEBI:17818; 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS113439; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; N-trans-Feruloyltyramine; C02717; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; N-Feruloyltyramine; 65646-26-6; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS-113439; 66648-43-9; Feruloyltyramine; moupinamide; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; ACon1_001233; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; MEGxp0_000693; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-, (2Z)-; 80510-09-4; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; Moupinamide; n-trans-feruloyltyramine; N-E-feruloyl tyramine; n-cis-feruloyltyramine |
C18H19NO4 |
313.3 g/mol |
COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC=C(C=C2)O)O |
TCMBANKIN061669 |
(-)-discretamine |
Prestwick3_000601; (13aS)-3,10-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,9-diol; (13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol; BPBio1_000554; CHEBI:17129; C02106; (13aS)-5,8,13,13a-tetrahydro-3,10-dimethoxy-6H-dibenzo[a,g]quinolizine-2,9-diol; BSPBio_000502; CHEMBL1395394; AKOS032949038; CAS-6451-73-6; AC1LMC5I; Scoulerine; ZINC28465423; (+)-Scoulerine; 4CN-3063; (13aR)-3,10-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,9-diol; BDBM50429050; NCGC00016674-01; scoulerine; (S)-Scoulerine |
C19H21NO4 |
327.4 g/mol |
COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)O)C=C1)O |
TCMBANKIN061676 |
aristolactam F I |
MCULE-4019596365; Piperolactam A; AC1MIW5I; Dibenz(cd,f)indol-4(5H)-one, 1-hydroxy-2-methoxy-; AKOS028108734; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2,4,6,8,12(16),13-HEPTAEN-11-ONE; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2(7),3,5,8,12(16),13-HEPTAEN-11-ONE; NP-013137; 112501-42-5; 1-Hydroxy-2-methoxydibenz(cd,f)indol-4(5H)-one; 1-Hydroxy-2-methoxydibenz[cd,f]indol-4(5H)-one, 9CI; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2(7),3,5,8,12,14-HEPTAEN-11-ONE; 1-Hydroxy-2-methoxy-Dibenz[cd,f]indol-4(5H)-one; 15-hydroxy-14-methoxy-10-azatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(15),2,4,6,8,12(16),13-heptaen-11-one; Aristolactam F1; AristolactamFI; CHEMBL387864; Dibenz[cd,f]indol-4(5H)-one, 1-hydroxy-2-methoxy-; NCGC00385457-01_C16H11NO3_1-Hydroxy-2-methoxydibenzo[cd,f]indol-4(5H)-one; Aristolactam FI; 1-Hydroxy-2-methoxy-Dibenz(cd,f)indol-4(5H)-one; Dibenz[cd,f]indol-4(5H)-one,1-hydroxy-2-methoxy-; ZINC13484719; DTXSID90150083; W1104; 4CN-2034; MolPort-005-945-747; piperolactam a |
C16H11NO3 |
265.26 g/mol |
COC1=C(C2=C3C(=C1)C(=O)NC3=CC4=CC=CC=C42)O |
TCMBANKIN061677 |
Cepharanone B |
Aristololactam bii; 37326-16-2; Dibenz[cd,f]indol-4(5H)-one, 1,2-dimethoxy-; Dibenz(cd,f)indol-4(5H)-one, 1,2-dimethoxy-; cepharanone b; 53948-09-7; AIDS224741; AIDS-224741 |
C17H13NO3 |
279.29 |
COC1=C(C2=C3C(=C1)C(=O)NC3=CC4=CC=CC=C42)OC |
TCMBANKIN061679 |
Oxoglaucine |
Noraporphin-7-one, 4,5,6,6a-tetradehydro-1,2,9,10-tetramethoxy-; oxoglaucine; MLS000574946; ZINC01726300; TNP00333; NCGC00142561-01; 7H-Dibenzo(de,g)quinolin-7-one, 1,2,9,10-tetramethoxy-; SMR000156317; O-Methylatheroline; NCGC00017383-01; ST057704; 7H-Dibenzo[de,g]quinolin-7-one, 1,2,9,10-tetramethoxy-; ATHEROLINE, O-METHYL; NSC141543; 5574-24-3; Liriodendron base |
C20H17NO5 |
351.4 g/mol |
COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=CC(=C(C=C42)OC)OC)OC |
TCMBANKIN061680 |
Oxonuciferine |
oxonuciferine; Oxonuciferine; 1,2-Dimethoxy-7H-dibenzo[de,g]quinolin-7-one; (+)-ushinsunine-beta-N-oxide; 15444-20-9; AKOS028110808; 15,16-DIMETHOXY-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(16),2,4,6,9,11,13(17),14-OCTAEN-8-ONE; lysicamine; NSC 628003; DPBMWJXWUINLQT-UHFFFAOYSA-N; DTXSID00165628; UNII-6L30DD6R7O; AIDS008762; BRN 1486372; 7H-Dibenzo[de,g]quinolin-7-one, 1,2-dimethoxy-; 5-21-13-00382 (Beilstein Handbook Reference); 1,2-Dimethoxy-7H-dibenzo(de,g)quinolin-7-one; Noraporphin-7-one, 4,5,6,6a-tetradehydro-1,2-dimethoxy-; 7H-Dibenzo(de,g)quinolin-7-one, 1,2-dimethoxy-; MolPort-044-754-181; CHEBI:70650; D01RUH; AC1L3V30; NSC-628003; 6L30DD6R7O; NSC628003; 1,2-Dimethoxy-7H-dibenzo[de,g]quinolin-7-one #; BDBM50292452; LS-97036; 7H-Dibenzo(de,g)quinolin-7-one, 1,2-dimethoxy- (9CI); AIDS-008762; SCHEMBL2046474; CCRIS 3813; CHEMBL510090; Lysicamine |
C18H13NO3 |
291.3 g/mol |
COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=CC=CC=C42)OC |
TCMBANKIN061700 |
artabonatine d |
Artabonatine |
C18H13NO4 |
307.3 g/mol |
COC1=C2C3=CC=CC=C3C(=O)C4=C2C(=C(C(=O)N4)OC)C=C1 |
TCMBANKIN061874 |
griffithinam |
gonioffithine |
C17H13NO4 |
295.29 g/mol |
COC1=CC=CC2=C3C4=C(C=C21)NC(=O)C4=CC(=C3O)OC |
TCMBANKIN061894 |
Dehydrocoreximine |
|
C19H18NO4+ |
324.3 g/mol |
COC1=CC2=C[NH+]3CCC4=CC(=C(C=C4C3=CC2=CC1=O)O)OC |